{"access":{"can_view":true,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":false,"can_get_doi":false,"can_share":true,"can_move":true,"can_move_outside":true,"can_transfer":true,"can_download":true,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"authors":[{"name":"Leonardo Teodoro de Farias","affiliation":"Universidade Federal de Goiás (UFG)","affiliation_url":null,"username":"n4vle122t105wle1","link":null,"image":{"source":"https://content.protocols.io/files/piamcbbe7.jpg","placeholder":"https://content.protocols.io/files/piamcbbe7.jpg","webp_source":"https://content.protocols.io/files/piakcbbe7.webp"},"note":"Farmacêutico (Centro Universitário de Anápolis - UniEVANGÉLICA, 2017); Especialista em Farmácia clínica e Hospitalar (UNINTER, 2019); Especialista em intensivismo, urgência e emergência (Residência multiprofissional em Saúde: Atenção ao paciente crítico - Universidade Federal de Mato Grosso do Sul, 2020); Especialista em Hematologia e Hemoterapia (Residência multiprofissional em Saúde: Hematologia e Hemoterapia - Universidade Federal de Goiás, 2022); Master em qualidade e acreditação em saúde (UniBF, 2023); MBA em Gestão, estratégia e inovação em serviços de saúde (UniBF, 2023); Mestrando do Programa de Assistência e Avaliação em Saúde (Universidade Federal de Goiás); Farmacêutico na Secretaria Municipal de Saúde de Goiânia.","is_verified_user":true},{"name":"Pryscila Rodrigues Moreira","affiliation":"Universidade Federal de Goiás (UFG)","affiliation_url":null,"username":"n4vle122t1y4tle1","link":null,"image":{"source":"https://lh3.googleusercontent.com/a/ACg8ocI4lZuTbkUN4azTHsIMYHi7uWec2RroaYuEyfO6j-b--OA=s96-c","placeholder":"https://lh3.googleusercontent.com/a/ACg8ocI4lZuTbkUN4azTHsIMYHi7uWec2RroaYuEyfO6j-b--OA=s96-c","webp_source":""},"note":"","is_verified_user":true},{"name":"Dra. Ana Carolina Figueiredo Modesto","affiliation":"Universidade Federal de Goiás (UFG)","affiliation_url":null,"username":"n4vle122t105xle1","link":null,"image":{"source":"/img/avatars/009.png","placeholder":"/img/avatars/009.png","webp_source":""},"note":"","is_verified_user":false}],"before_start":"","book_chapter":null,"can_accept_authorship":false,"can_be_copied":true,"can_claim_authorship":false,"can_manage_keywords":true,"can_remove_fork":false,"can_sign":false,"child_steps":{},"cited_protocols":[],"collection_items":[],"created_on":1705086553,"creator":{"name":"Leonardo Teodoro de Farias","affiliation":"","affiliation_url":null,"username":"n4vle122t105wle1","link":null,"image":{"source":"https://content.protocols.io/files/piamcbbe7.jpg","placeholder":"https://content.protocols.io/files/piamcbbe7.jpg","webp_source":"https://content.protocols.io/files/piakcbbe7.webp"},"badges":[{"id":2,"name":"Author","image":{"source":"/img/badges/bronze.svg","placeholder":"/img/badges/bronze.svg"}}],"affiliations":[]},"cross_cloud_origin":null,"description":"{\"blocks\":[{\"key\":\"5ua3c\",\"text\":\"Objetivo\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":8}],\"entityRanges\":[],\"data\":{}},{\"key\":\"fcemc\",\"text\":\"O objetivo deste protocolo é fornecer diretrizes para o manejo das doses de medicamentos para tratamento de mieloma múltiplo em função do grau de neuropatia periférica induzida por quimioterapia (NPIQ). A pesquisa foi feita utilizando as bases de dados oficiais e o Up to Date, além de recomendações do fabricante de cada medicamento. Este protocolo leva em consideração os Medicamentos aprovados para o tratamento do mieloma múltiplo no Brasil.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"dcg0c\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4kt82\",\"text\":\"População-alvo\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"bold\",\"offset\":0,\"length\":14}],\"entityRanges\":[],\"data\":{}},{\"key\":\"72ibp\",\"text\":\"Este protocolo se aplica a todos os pacientes com mieloma múltiplo que estão recebendo tratamento com medicamentos que podem causar NPIQ.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9pq30\",\"text\":\"\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"lghs\",\"text\":\"\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"cqo0g\",\"text\":\"Esse protocolo visa fornecer diretrizes claras para o ajuste de doses em pacientes com mieloma múltiplo, considerando a presença de neuropatia periférica induzida por quimioterapia. Recomenda-se consulta frequente às bases de dados e revisões periódicas deste protocolo para incorporar novas evidências e melhores práticas.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","disclaimer":"","document":"","documents":null,"doi":"dx.doi.org/10.17504/protocols.io.n2bvj3m3nlk5/v1","doi_status":1,"ethics_statement":null,"fork_id":null,"fork_info":null,"forks":[],"funders":[],"groups":[],"guid":"583B2C164A1441E99B0F26EA930FD807","guidelines":"","has_references":true,"has_step_reagents":false,"has_versions":false,"id":93463,"image":{"source":"https://content.protocols.io/files/pickcbbe7.jpg","webp_source":"https://content.protocols.io/files/picjcbbe7.webp","placeholder":"","webp_placeholder":""},"image_attribution":"","in_trash":false,"is_bookmarked":false,"is_contact_suspended":false,"is_content_confidential":false,"is_content_warning":false,"is_doi_reserved":false,"is_in_pending_publishing":false,"is_in_transfer":false,"is_owner":true,"is_research":true,"is_retracted":false,"is_shared_directly":false,"is_subprotocol":null,"is_unlisted":false,"item_id":1205721,"journal":null,"journals":[],"keywords":"Mieloma Múltiplo,Ajuste de dose de medicamento,Neuropatia Periférica Induzida por Quimioterapia","last_modified":1705101348,"link":"","location":null,"manuscript_citation":"","materials":[],"materials_text":"","ownership_history":null,"parent_collections":[],"parent_protocols":[],"peer_reviewed":false,"protocol_references":"{\"blocks\":[{\"key\":\"5moca\",\"text\":\"BORTEZOMIB: PATIENT DRUG INFORMATION - UPTODATE. [S. l.], [s.d.]. Disponível em: https://www.uptodate.com/contents/bortezomib-patient-drug-information search=bortezomibe\\u0026topicRef=8509\\u0026source=see_link.Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":50,\"length\":5},{\"style\":\"italic\",\"offset\":59,\"length\":4}],\"entityRanges\":[],\"data\":{}},{\"key\":\"8oreq\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"fh9l8\",\"text\":\"CARFILZOMIB: DRUG INFORMATION - UPTODATE. [S. l.], [s. d.]. Disponível em: https://www.uptodate.com/contents/carfilzomib-drug-information search=carfilzomib\\u0026source=panel_search_result\\u0026selectedTitle=1~40\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1.Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":43,\"length\":5},{\"style\":\"italic\",\"offset\":52,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"fu15k\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7jud4\",\"text\":\"CYCLOPHOSPHAMIDE: DRUG INFORMATION - UPTODATE. [S. l.], [s. d.]. Disponível em: https://www.uptodate.com/contents/cyclophosphamide-drug-information search=ciclofosfamida\\u0026source=panel_search_result\\u0026selectedTitle=1~148\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":48,\"length\":5},{\"style\":\"italic\",\"offset\":57,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"1mels\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9iq08\",\"text\":\"DARATUMUMAB (INTRAVENOUS): DRUG INFORMATION - UPTODATE. [S. l.], [s. d.]. Disponível em: https://www.uptodate.com/contents/daratumumab-intravenous-drug-information search=daratumumab\\u0026selectedTitle=1~54\\u0026usage_type=panel\\u0026display_rank=1\\u0026kp_tab=drug_general\\u0026source=panel_sea ch_result. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":57,\"length\":5},{\"style\":\"italic\",\"offset\":66,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"4g8od\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9sa38\",\"text\":\"DENOSUMAB: DRUG INFORMATION - UPTODATE. [S.l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/denosumab-drug-information?search=denosumab\\u0026source=panel_search_result\\u0026selectedTitle=1~103\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":41,\"length\":4},{\"style\":\"italic\",\"offset\":49,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"6il90\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"d4oho\",\"text\":\"DEXAMETHASONE (SYSTEMIC): DRUGINFORMATION - UPTODATE. [S. l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/dexamethasone-systemic-drug-information?search=dexametasona\\u0026source=panel_search_result\\u0026selectedTitle=1~145\\u0026usage_type=panel\\u0026showDrugLabel=true\\u0026display_rank=1.Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":55,\"length\":5},{\"style\":\"italic\",\"offset\":64,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"c5brl\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"uqud\",\"text\":\"ELOTUZUMAB: DRUG INFORMATION - UPTODATE.[S. l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/elotuzumab-drug-information?search=elotuzumabe\\u0026source=panel_search_result\\u0026selectedTitle=1~16\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1.Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":41,\"length\":5},{\"style\":\"italic\",\"offset\":50,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"p321\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2lkur\",\"text\":\"ISATUXIMAB: DRUG INFORMATION - UPTODATE.[S. l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/isatuximab-drug-information?search=isatuximabe\\u0026source=panel_search_result\\u0026selectedTitle=1~18\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":41,\"length\":5},{\"style\":\"italic\",\"offset\":50,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"d199k\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"70jk8\",\"text\":\"LENALIDOMIDE: DRUG INFORMATION - UPTODATE. [S. l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/lenalidomide-drug-information?search=lenalidomida\\u0026source=panel_search_result\\u0026selectedTitle=1~139\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":44,\"length\":5},{\"style\":\"italic\",\"offset\":53,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"1b56f\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ro9a\",\"text\":\"MELPHALAN: DRUG INFORMATION - UPTODATE. [S.l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/melphalan-drug-information?search=melfalano\\u0026selectedTitle=1~123\\u0026usage_type=panel\\u0026display_rank=1\\u0026kp_tab=drug_general\\u0026source=panel_search_result. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":41,\"length\":4},{\"style\":\"italic\",\"offset\":49,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"6qgrv\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"epsmp\",\"text\":\"PAMIDRONATE: DRUG INFORMATION - UPTODATE.[S. l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/pamidronate-drug-information?search=pamidronato\\u0026source=panel_search_result\\u0026selectedTitle=1~69\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":42,\"length\":5},{\"style\":\"italic\",\"offset\":51,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"e9gvt\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"f41oo\",\"text\":\"PREDNISONE: DRUG INFORMATION - UPTODATE.[S. l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/prednisone-drug-information?search=prednisona\\u0026source=panel_search_result\\u0026selectedTitle=1~148\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":41,\"length\":5},{\"style\":\"italic\",\"offset\":50,\"length\":5}],\"entityRanges\":[],\"data\":{}},{\"key\":\"da4sa\",\"text\":\"\",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9vsif\",\"text\":\"THALIDOMIDE: DRUG INFORMATION - UPTODATE.[S. l.], [s. d.]. Disponível em:\\nhttps://www.uptodate.com/contents/thalidomide-drug-information?search=talidomida\\u0026source=panel_search_result\\u0026selectedTitle=1~148\\u0026usage_type=panel\\u0026kp_tab=drug_general\\u0026display_rank=1. Acesso em: 12 jan. 2024. \",\"type\":\"unstyled\",\"depth\":0,\"inlineStyleRanges\":[{\"style\":\"italic\",\"offset\":42,\"length\":5},{\"style\":\"italic\",\"offset\":51,\"length\":5}],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","public":true,"public_fork_note":"","published_on":1705101348,"references":[],"related_equipments":[],"related_materials":[],"reserved_doi":"","retraction_reason":null,"samples":{},"shared_access_id":0,"show_comparison":false,"sign_info":null,"space_access":{"can_view":false,"can_edit":false,"can_remove":false,"can_add":false,"can_publish":true,"can_get_doi":true,"can_share":false,"can_move":false,"can_move_outside":false,"can_transfer":false,"can_download":false,"limited_run":false,"limited_private_links":false,"limited_blind_links":false,"is_locked":false},"space_id":113195,"state_version_id":303,"stats":{"is_voted":false,"number_of_views":9,"number_of_steps":12,"number_of_bookmarks":0,"number_of_comments":0,"number_of_bookmarked_comments":0,"number_of_steps_comments":0,"number_of_protocol_comments":0,"number_of_exports":0,"number_of_runs":0,"number_of_votes":0,"number_of_reagents":0,"number_of_equipments":0,"number_of_collections":0,"number_of_forks":{"private":0,"public":0},"number_of_accessible_forks":0},"status":{"id":1,"info":"We use this protocol and it's working"},"steps":[{"id":1902477,"guid":"037C6C220F4F4385A81DA431083C0D66","previous_id":0,"previous_guid":null,"section":"\u003cp\u003eIXAZOMIBE:\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"fqihs\",\"text\":\"Mecanismo de Ação: Inibe reversivelmente os proteassomas, regulando a homeostase proteica intracelular.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7jbp7\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"emi0s\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"b6bds\",\"text\":\"Grau 1 ou Grau 2 (com dor): Suspender o ixazomibe até que a neuropatia periférica se recupere para ≤ grau 1 sem dor ou até o valor basal. Após recuperação, retomar o ixazomibe na dose utilizada antes da interrupção.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"8fff5\",\"text\":\"Grau 2 (com dor) ou Grau 3: Suspender ixazomibe até recuperação ao valor basal ou melhora para ≤ grau 1 (a critério do médico). Após recuperação, reiniciar o ixazomibe na próxima dose mais baixa. \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"5sq4b\",\"text\":\"Grau 3 ou 4: Suspender ixazomibe até recuperação ao valor basal ou melhora para ≤ grau 1 (a critério do médico). Se atribuível ao ixazomibe, retomar o ixazomibe na próxima dose mais baixa.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"1","cases":[],"critical":null},{"id":1902481,"guid":"F3C188D946B0434886C7ACFFFB5B4637","previous_id":1902477,"previous_guid":"037C6C220F4F4385A81DA431083C0D66","section":"\u003cp\u003eCARFILZOMIBE:\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"2eo9s\",\"text\":\"Mecanismo de Ação: Inibe os proteassomas, induzindo parada do ciclo celular e apoptose.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"f6uhr\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"52rnr\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"c1ccg\",\"text\":\"Nenhum ajuste de dose inicial é necessário de acordo com fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"2","cases":[],"critical":null},{"id":1902482,"guid":"BF0FC8C4F3994312B3C73CCBF5928C44","previous_id":1902481,"previous_guid":"F3C188D946B0434886C7ACFFFB5B4637","section":"\u003cp\u003eBORTEZOMIBE:\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"dk0r1\",\"text\":\"Mecanismo de Ação: Inibe reversivelmente a atividade semelhante à quimotripsina no proteassoma 26S, levando à ativação de cascatas de sinalização, parada do ciclo celular e apoptose.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"25r74\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"8pkok\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"apds2\",\"text\":\"Grau 1: Não é necessária modificação de dose.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"1m6i6\",\"text\":\"Grau 1 com dor ou Grau 2: Reduzir a dose de bortezomibe para 1 mg/m².\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"9a38q\",\"text\":\"Grau 2 com dor ou Grau 3: Suspender o bortezomibe até que a toxicidade seja resolvida; após resolução, retomar o bortezomibe em uma dose reduzida de 0,7 mg/m².\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"a9qjq\",\"text\":\"Grau 4: Suspenda o bortezomibe.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"3","cases":[],"critical":null},{"id":1902483,"guid":"970E231B8EA7428FBAD9F189028ED7DC","previous_id":1902482,"previous_guid":"BF0FC8C4F3994312B3C73CCBF5928C44","section":"\u003cp\u003eLENALIDOMIDA:\u003c/p\u003e","section_color":"#FFED92","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"cr2bi\",\"text\":\"Mecanismo de Ação: Possui características imunomoduladoras, antiangiogênicas e antineoplásicas.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"b4j0q\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"dnsn9\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"di39f\",\"text\":\"Não há informações sobre ajuste de dose pelo fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"4","cases":[],"critical":null},{"id":1902484,"guid":"F0634167D8484E72A7288A846376480C","previous_id":1902483,"previous_guid":"970E231B8EA7428FBAD9F189028ED7DC","section":"\u003cp\u003eTALIDOMIDA:\u003c/p\u003e","section_color":"#EA9F6C","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"eg18c\",\"text\":\"Mecanismo de Ação: Apresenta características imunomoduladoras e antiangiogênicas.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"3inf1\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"59b0r\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"e99op\",\"text\":\"Grau 1: Reduzir a dose em 50%.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"6hb2p\",\"text\":\"Grau 2: Interromper temporariamente a terapia; uma vez resolvido para ≤ grau 1, retomar a terapia com uma redução de 50% da dose (se clinicamente apropriado).\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"btptu\",\"text\":\"Grau 3 ou Superior: Descontinuar a terapia.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"5","cases":[],"critical":null},{"id":1902485,"guid":"5045D35A9A1F4FB8B773EF4C46756250","previous_id":1902484,"previous_guid":"F0634167D8484E72A7288A846376480C","section":"\u003cp\u003eDARATUMUMABE:\u003c/p\u003e","section_color":"#E57785","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"ebtre\",\"text\":\"Mecanismo de Ação: Anticorpo monoclonal dirigido contra CD38, induzindo apoptose em células\\ntumorais.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"fgghl\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"62s4q\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"abdc6\",\"text\":\"Nenhum ajuste de dose inicial é necessário de acordo com fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"6","cases":[],"critical":null},{"id":1902486,"guid":"485FFECCC2CC4F1CA97C026AC027A7A3","previous_id":1902485,"previous_guid":"5045D35A9A1F4FB8B773EF4C46756250","section":"\u003cp\u003eELOTUZUMABE:\u003c/p\u003e","section_color":"#EA94FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"f6qlr\",\"text\":\"Mecanismo de Ação: Anticorpo monoclonal dirigido contra SLAMF7.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"c7pp7\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"8gn5b\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"7l2nk\",\"text\":\"Não há informações sobre ajuste de dose pelo fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"7","cases":[],"critical":null},{"id":1902488,"guid":"91FAC619891F4A528443EAC96B44487F","previous_id":1902486,"previous_guid":"485FFECCC2CC4F1CA97C026AC027A7A3","section":"\u003cp\u003eISATUXIMAB-IFRC:\u003c/p\u003e","section_color":"#A492FF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"1n1f1\",\"text\":\"Mecanismo de Ação: Anticorpo monoclonal derivado de IgG1 direcionado contra CD38.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"a6id6\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2flce\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"6a22a\",\"text\":\"Não há informações sobre ajuste de dose pelo fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"8","cases":[],"critical":null},{"id":1902489,"guid":"0C406690C65E4F889BDA2882BD71F6AA","previous_id":1902488,"previous_guid":"91FAC619891F4A528443EAC96B44487F","section":"\u003cp\u003eMELFALANO:\u003c/p\u003e","section_color":"#94EBFF","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"7tmnc\",\"text\":\"Mecanismo de Ação: Agente alquilante inibindo a síntese de DNA e RNA.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"c00u4\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"dcu11\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2bjl6\",\"text\":\"Nenhum ajuste de dose inicial é necessário de acordo com fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"9","cases":[],"critical":null},{"id":1902490,"guid":"BFB919C7989641A7973F0AEA9F3AF182","previous_id":1902489,"previous_guid":"0C406690C65E4F889BDA2882BD71F6AA","section":"\u003cp\u003eCICLOFOSFAMIDA:\u003c/p\u003e","section_color":"#84CE84","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"9seke\",\"text\":\"Mecanismo de Ação: Agente alquilante que previne a divisão celular.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"1l74l\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"v4n4\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"2a8m8\",\"text\":\"Nenhum ajuste de dose inicial é necessário de acordo com fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"10","cases":[],"critical":null},{"id":1902491,"guid":"54C0D079F2764A37A54A07F87E10E845","previous_id":1902490,"previous_guid":"BFB919C7989641A7973F0AEA9F3AF182","section":"\u003cp\u003eDEXAMETASONA:\u003c/p\u003e","section_color":"#FFED92","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"1b2co\",\"text\":\"Mecanismo de Ação: Corticosteroide de ação prolongada com potencial mínimo de retenção de sódio.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"cnh14\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"6nobg\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"ciq8q\",\"text\":\"Não há informações sobre ajuste de dose pelo fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"11","cases":[],"critical":null},{"id":1902492,"guid":"B5A30310FE9F490398BE465FE2B34279","previous_id":1902491,"previous_guid":"54C0D079F2764A37A54A07F87E10E845","section":"\u003cp\u003ePREDNISONA:\u003c/p\u003e","section_color":"#EA9F6C","section_duration":0,"is_substep":false,"step":"{\"blocks\":[{\"key\":\"1bmbo\",\"text\":\"Mecanismo de Ação: Suprime o sistema imunológico e reduz a atividade do sistema linfático.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"4bijk\",\"text\":\" \",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"c2ect\",\"text\":\"Manejo de Dose para NPIQ:\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}},{\"key\":\"c0chq\",\"text\":\"Não há informações sobre ajuste de dose pelo fabricante.\",\"type\":\"align-justify\",\"depth\":0,\"inlineStyleRanges\":[],\"entityRanges\":[],\"data\":{}}],\"entityMap\":{}}","data":null,"protocol_id":93463,"case_id":0,"critical_ids":"","duration":0,"original_id":0,"number":"12","cases":[],"critical":null}],"template_id":1,"title":"Protocolo de Manejo das Doses de Medicamentos para Tratamento de Mieloma Múltiplo em Função do Grau de Neuropatia Periférica Induzida por Quimioterapia (NPIQ)","title_html":"Protocolo de Manejo das Doses de Medicamentos para Tratamento de Mieloma Múltiplo em Função do Grau de Neuropatia Periférica Induzida por Quimioterapia (NPIQ)","type_id":1,"units":[{"id":1,"type_id":3,"name":"µL","can_manage":0,"read_only":0},{"id":2,"type_id":3,"name":"mL","can_manage":0,"read_only":0},{"id":3,"type_id":3,"name":"L","can_manage":0,"read_only":0},{"id":4,"type_id":3,"name":"µg","can_manage":0,"read_only":0},{"id":5,"type_id":3,"name":"mg","can_manage":0,"read_only":0},{"id":6,"type_id":3,"name":"g","can_manage":0,"read_only":0},{"id":7,"type_id":3,"name":"kg","can_manage":0,"read_only":0},{"id":8,"type_id":3,"name":"ng","can_manage":0,"read_only":0},{"id":9,"type_id":3,"name":"Hz","can_manage":0,"read_only":0},{"id":10,"type_id":24,"name":"°C","can_manage":0,"read_only":0},{"id":11,"type_id":24,"name":"°К","can_manage":0,"read_only":0},{"id":12,"type_id":24,"name":"°F","can_manage":0,"read_only":0},{"id":13,"type_id":25,"name":"Mass Percent","can_manage":0,"read_only":0},{"id":14,"type_id":25,"name":"% volume","can_manage":0,"read_only":0},{"id":15,"type_id":25,"name":"Mass / % volume","can_manage":0,"read_only":0},{"id":16,"type_id":25,"name":"Parts per Million (PPM)","can_manage":0,"read_only":0},{"id":17,"type_id":25,"name":"Parts per Billion (PPB)","can_manage":0,"read_only":0},{"id":18,"type_id":25,"name":"Parts per Trillion (PPT)","can_manage":0,"read_only":0},{"id":19,"type_id":25,"name":"Mole Fraction","can_manage":0,"read_only":0},{"id":20,"type_id":25,"name":"Mole Percent","can_manage":0,"read_only":0},{"id":21,"type_id":25,"name":"Molarity (M)","can_manage":0,"read_only":1},{"id":22,"type_id":25,"name":"Molarity (m)","can_manage":0,"read_only":0},{"id":23,"type_id":25,"name":"Genome copies per ml","can_manage":0,"read_only":0},{"id":24,"type_id":3,"name":"μV","can_manage":0,"read_only":0},{"id":25,"type_id":3,"name":"ms","can_manage":0,"read_only":0},{"id":26,"type_id":3,"name":"pg","can_manage":0,"read_only":0},{"id":27,"type_id":25,"name":"Molarity dilutions","can_manage":0,"read_only":0},{"id":28,"type_id":25,"name":"millimolar (mM)","can_manage":0,"read_only":0},{"id":29,"type_id":25,"name":"micromolar (µM)","can_manage":0,"read_only":0},{"id":30,"type_id":25,"name":"nanomolar (nM)","can_manage":0,"read_only":0},{"id":31,"type_id":25,"name":"picomolar (pM)","can_manage":0,"read_only":0},{"id":32,"type_id":24,"name":"Room temperature","can_manage":0,"read_only":0},{"id":33,"type_id":30,"name":"rpm","can_manage":0,"read_only":0},{"id":34,"type_id":30,"name":"x g","can_manage":0,"read_only":0},{"id":165,"type_id":24,"name":"On ice","can_manage":0,"read_only":0},{"id":200,"type_id":32,"name":"cm","can_manage":0,"read_only":0},{"id":201,"type_id":32,"name":"mm","can_manage":0,"read_only":0},{"id":202,"type_id":32,"name":"µm","can_manage":0,"read_only":0},{"id":203,"type_id":32,"name":"nm","can_manage":0,"read_only":0},{"id":204,"type_id":25,"name":"mg/mL","can_manage":0,"read_only":0},{"id":205,"type_id":25,"name":"µg/µL","can_manage":0,"read_only":0},{"id":206,"type_id":25,"name":"% (v/v)","can_manage":0,"read_only":0},{"id":207,"type_id":3,"name":"V","can_manage":0,"read_only":0},{"id":1324,"type_id":30,"name":"rcf","can_manage":0,"read_only":0},{"id":1359,"type_id":35,"name":"Bar","can_manage":0,"read_only":0},{"id":1360,"type_id":35,"name":"Pa","can_manage":0,"read_only":0}],"uri":"protocolo-de-manejo-das-doses-de-medicamentos-para-c7hxzj7n","url":"https://www.protocols.io/view/protocolo-de-manejo-das-doses-de-medicamentos-para-c7hxzj7n","version_class":93463,"version_data":{"id":0,"code":"c7hxzj7n","version_class":93463,"parent_id":null,"parent_uri":null,"is_same_owner":false,"is_parent_public":false,"has_pending_merge_request":false,"has_approved_merge_request":false,"merge_request":null},"version_id":0,"version_uri":"protocolo-de-manejo-das-doses-de-medicamentos-para-n2bvj3m3nlk5/v1","versions":[{"id":93463,"title":"Protocolo de Manejo das Doses de Medicamentos para Tratamento de Mieloma Múltiplo em Função do Grau de Neuropatia Periférica Induzida por Quimioterapia (NPIQ)","title_html":"Protocolo de Manejo das Doses de Medicamentos para Tratamento de Mieloma Múltiplo em Função do Grau de Neuropatia Periférica Induzida por Quimioterapia (NPIQ)","image":{"source":"https://content.protocols.io/files/pickcbbe7.jpg","webp_source":null,"placeholder":"https://content.protocols.io/files/pickcbbe7.jpg","webp_placeholder":null},"doi":"dx.doi.org/10.17504/protocols.io.n2bvj3m3nlk5/v1","uri":"protocolo-de-manejo-das-doses-de-medicamentos-para-c7hxzj7n","published_on":1705101348,"modified_on":1705101348,"version_class":93463,"version_id":0,"version_code":"c7hxzj7n","version_uri":"protocolo-de-manejo-das-doses-de-medicamentos-para-n2bvj3m3nlk5/v1","created_on":1705086553,"categories":null,"type_id":1,"creator":{"name":"Leonardo Teodoro de Farias","affiliation":null,"affiliation_url":null,"username":"n4vle122t105wle1","link":null,"image":{"source":"https://content.protocols.io/files/piamcbbe7.jpg","placeholder":"https://content.protocols.io/files/piamcbbe7.jpg","webp_source":"https://content.protocols.io/files/piakcbbe7.webp"}},"stats":{"number_of_comments":0,"last_comment_time":0}}],"warning":""}